PT - JOURNAL ARTICLE AU - Nielsen, Bjarke Frost AU - Sneppen, Kim TI - Superspreaders provide essential clues for mitigation of COVID-19 AID - 10.1101/2020.09.15.20195008 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.15.20195008 4099 - http://medrxiv.org/content/early/2020/09/18/2020.09.15.20195008.short 4100 - http://medrxiv.org/content/early/2020/09/18/2020.09.15.20195008.full AB - Although coronavirus disease 2019 (COVID-19) has caused severe suffering in many countries around the world, the efficacy of non-pharmaceutical interventions such as policies of social distancing has been greater than models have predicted. Meanwhile, evidence is mounting that the pandemic is characterized by superspreading, where a small fraction account for the majority of infections. Capturing this phenomenon theoretically requires modeling at the scale of individuals. Using a mathematical model, we show that superspreading represents an Achilles’ heel of COVID-19, and drastically improves the efficacy of mitigations which reduce the personal contact number, even when this is done without changing the average social contact time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur research has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, grant agreement No. 740704.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code developed for use in this study can be obtained from the authors by reasonable request.